MyBCTeam

Trodelvy (sacituzumab govitecan-hziy) is used to treat metastatic triple-negative breast cancer. Common side effects include:

- Nausea
- Neutropenia (low white blood cell count)
- Diarrhea
- Fatigue
- Anemia (low red blood cell count)
- Vomiting
- Hair loss
- Constipation
- Rash
- Decreased appetite
- Abdominal pain

Rare Show Full Answer

Trodelvy (sacituzumab govitecan-hziy) is used to treat metastatic triple-negative breast cancer. Common side effects include:

- Nausea
- Neutropenia (low white blood cell count)
- Diarrhea
- Fatigue
- Anemia (low red blood cell count)
- Vomiting
- Hair loss
- Constipation
- Rash
- Decreased appetite
- Abdominal pain

Rare but serious side effects include severe hypersensitivity reactions, very low white blood cell counts, severe nausea and vomiting, and fetal harm. Always consult your healthcare provider for personalized advice.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Trodelvy (Sacituzumab govitecan-hziy) for Breast Cancer | MyBCTeam

5 Treatments for Triple-Negative Breast Cancer and Common Side Effects | MyBCTeam